Showing posts with label Europe. Show all posts
Showing posts with label Europe. Show all posts

Wednesday, August 31, 2011

Flu update: May through August

  
In May, June, July and August 2011, Influenza activity was low in North America, Europe, Northern Asia, Middle East and North Africa. Tepid latitudes of Northern hemisphere remained at baseline inter-seasonal levels.

The 2011 influenza season in South Africa peaked in the end of June. The majority of samples were identified as 2009 H1N1 virus. Flu levels were still moderate in early July but illness activity became low by the end of July.

Dominican Republic, Cuba, Honduras and Brazil observed moderate activity (peak was in the end of June/beginning of July). Columbia had active circulation of 2009 H1N1 virus, but there were no new cases in July and August. Illness levels in Peru and Bolivia also returned to low levels.

Flu activity in August was low in countries of Western Africa (Ghana, Cameroon and Senegal), and Southern Asia (India, Bangladesh, Thailand, and Singapore).  Google flu trends predicted increased activity for South Africa and Chile in June-July and Uruguay in July-August. WHO data showed that flu levels returned to low in South Africa, but started to increase for Chile, Uruguay and Argentina marking the peak of the season.

In Australia, influenza-like illness consultations and laboratory-confirmed cases continue to increase.
The flu season started in the end of April, rates slightly declined in mid May but kept increasing since.  The most common virus was influenza A(H1N1)2009 but influenza B was also prevalent, unevenly distributed across the country.

According to the ESR Kenepuru Science Centre and the WHO, flu incidents in New Zealand increased from mid-May through the end of July, but decreased during the first two weeks of August. ILI activity in New Zealand remained around expected levels and the majority of viruses detected have been influenza B.

See the latest CDC  Global and WHO updates for more.

Sunday, February 20, 2011

Flu update: Have we passed the peak?

According to WHO, the highest influenza rates were in Asia, with notable increases in respiratory disease activity in Singapore and Hong Kong, and the majority of cases tested positive for 2009 H1N1. Influenza activity appears to have peaked in the majority of North African and Middle Eastern countries with the exception of Algeria, where rates increased. The percentage of respiratory specimens testing positive for influenza was also high in Pakistan, Iran and Oman. Influenza cases in southern China decreased from its peak earlier this season.Although influenza activity was sparse in the tropical Americas and sub-Saharan Africa, it increased in Madagascar. Influenza activity remained low in the temperate Southern Hemisphere.
 According to the Public Health Agency of Canada, influenza activity increased slightly, but remained below the peak observed earlier this season.

In US, the following ILI activity levels were experienced:
  • Twenty-one states (Alabama, Arkansas, California, Colorado, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Louisiana, Missouri, New Jersey, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia) experienced high ILI activity.
  • Six states (Alaska, Arizona, Connecticut, Massachusetts, Pennsylvania, and Utah) experienced moderate ILI activity.
  • New York City and 16 states (Delaware, Florida, Kentucky, Maryland, Minnesota, Mississippi, Nebraska, Nevada, New York, North Dakota, Ohio, Oregon, South Dakota, Washington, Wisconsin, and Wyoming) experienced low ILI activity.
  • Minimal ILI activity was experienced by seven states (Iowa, Maine, Michigan, Montana, New Hampshire, Rhode Island, and Vermont).
    Click on map to launch interactive tool


In Europe, activity moved past its peak, although it was still intense in Luxembourg, Georgia and the Siberian region of the Russian Federation (source).


Intensity Geographic
Spread
Impact Sentinel
swabs
Percentage
positive
Dominant
type
ILI per
100,000
ARI per
100,000
Sentinel
SARI
Virology graph
and pie chart
AlbaniaHighLocalModerate375.4%None

494.3 (graphs)
Click here
ArmeniaMediumLocalModerate50%None0.0 (graphs)91.2 (graphs)


sari
Click here
AustriaMediumWidespreadLow6965.2%Type A, Subtype pH1N10.0 (graphs)35.2 (graphs)
Click here
AzerbaijanLowSporadicLow220%None314.2 (graphs)


Click here
BelarusMediumLocalModerate2951.7%Type A, Subtype pH1

1756.0 (graphs)
Click here
BelgiumMediumWidespread
5062.0%Type B and Type A, Subtype pH1N1328.2 (graphs)1573.2 (graphs)
Click here
Bosnia and Herzegovina




Type A, Subtype pH1
(graphs)


Click here
BulgariaMediumRegional
1070.0%Type A, Subtype pH10.0 (graphs)1339.0 (graphs)
Click here
CroatiaHighWidespreadLow

Type A, Subtype pH1221.2 (graphs)


Click here
CyprusLowLocalLow


1.5 * (graphs)8.0 * (graphs)
Click here
Czech RepublicMediumWidespread
2982.8%Type A, Subtype pH1N1226.1 (graphs)1435.3 (graphs)
Click here
DenmarkMediumWidespread
3813.2%None (graphs)0.0 (graphs)
Click here
EnglandLowSporadic
9614.6%Type A and B12.1 (graphs)390.9 (graphs)
Click here
EstoniaMediumWidespread
4015.0%Type A, Subtype pH118.4 (graphs)437.3 (graphs)
Click here
Finland
Widespread
4833.3%Type B and Type A, Subtype pH1N10.0 (graphs)0.0 (graphs)
Click here
FranceMediumWidespreadLow17545.7%Type B and Type A, Subtype pH1N10.0 (graphs)2369.6 (graphs)
Click here
GeorgiaVery HighWidespreadSevere4893.8%Type B and Type A, Subtype pH11454.7 (graphs)




sari
Click here
GermanyMediumRegional
24250.8%Type A, Subtype pH1N10.0 (graphs)1309.0 (graphs)
Click here
GreeceHighWidespread
3759.5%Type A, Subtype pH1N1399.9 (graphs)0.0 (graphs)
Click here
HungaryMediumWidespreadModerate14311.9%Type A, Subtype pH1475.6 (graphs)0.0 (graphs)
Click here
IcelandMediumRegionalModerate00%
75.2 (graphs)0.0 (graphs)
Click here
IrelandMediumRegionalLow4731.9%Type B36.2 (graphs)0.0 (graphs)
Click here
IsraelMediumWidespreadModerate4134.2%Type A and B35.0 (graphs)


Click here
ItalyHighWidespreadModerate11355.8%Type A, Subtype pH1N1768.5 (graphs)0.0 (graphs)
Click here
KazakhstanMediumLocalModerate1492.9%None1.9 (graphs)365.9 (graphs)


sari
Click here
KyrgyzstanLowSporadicLow1060.0%Type A and B8.6 (graphs)45.9 (graphs)


sari
Click here
LatviaMediumWidespread
933.3%Type B (graphs)


Click here
LithuaniaHighWidespreadLow


85.8 (graphs)660.7 (graphs)
Click here
Luxembourg


5858.6%Type B and Type A, Subtype pH1 (graphs)


Click here
MaltaLowLocalLow


9.2 * (graphs)0 * (graphs)
Click here
NetherlandsMediumWidespread
3253.1%Type B60.4 (graphs)0.0 (graphs)
Click here
Northern IrelandLowSporadic
1010.0%Type B29.9 (graphs)359.2 (graphs)
Click here
NorwayLowWidespread
742.9%Type B and Type A, Subtype pH1120.0 (graphs)0.0 (graphs)
Click here
PolandMediumRegional
10223.5%Type A, Subtype pH1171.8 (graphs)0.0 (graphs)
Click here
PortugalLowSporadic
30%Type A, Subtype pH131.5 (graphs)0.0 (graphs)
Click here
Republic of MoldovaMediumLocalModerate8457.1%Type B and Type A, Subtype pH1N127.0 (graphs)470.0 (graphs)


sari
Click here
RomaniaHighWidespreadModerate3083.3%Type B and Type A, Subtype pH1N141.6 (graphs)1260.4 (graphs)


sari
Click here
Russian FederationHighWidespreadModerate6639.4%Type A, Subtype pH138.4 (graphs)1096.3 (graphs)


sari
Click here
ScotlandLowLocalLow4522.2%Type B2.2 (graphs)253.2 (graphs)
Click here
SerbiaHighRegionalModerate1100.0%Type A, Subtype pH1N1204.6 (graphs)




sari
Click here
SlovakiaMediumLocalLow2365.2%Type A, Subtype pH1487.9 (graphs)2514.5 (graphs)
Click here
SloveniaMediumWidespread
2365.2%Type B and Type A, Subtype pH169.6 (graphs)1499.3 (graphs)
Click here
SpainMediumRegional
24631.7%Type B113.6 (graphs)0.0 (graphs)
Click here
SwedenHighWidespreadLow3327.3%Type B19.5 (graphs)0.0 (graphs)
Click here
SwitzerlandMediumWidespread
6576.9%Type B and Type A, Subtype pH1276.8 (graphs)


Click here
TurkeyMediumLocalModerate10740.2%None
(graphs)


Click here
UkraineMediumLocalLow425.0%Type A and B5.2 * (graphs)674.7 (graphs)


sari
Click here
WalesLowSporadicLow


6.2 (graphs)0.0 (graphs)
Click here
Europe


229142.2%




Click here

Thursday, February 10, 2011

Flu Season is not over yet, but February marks the peak

As of mid February 2011, influenza activity in the United States remains elevated, but it appears to have peaked in the majority of European, North African and Middle Eastern countries.



  • There were more outpatient visits for influenza-like illness (ILI): 4.5% vs the national baseline of 2.5%, it was above region-specific baseline levels in all US regions. 
    • Twenty states (Alabama, Arkansas, Colorado, Georgia, Idaho, Indiana, Louisiana, Maryland, Missouri, New Jersey, New Mexico, New York, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Utah, Virginia, and West Virginia) experienced high ILI activity.
    • Nine states (California, Florida, Hawaii, Illinois, Kansas, Kentucky, Mississippi, Pennsylvania, and Wyoming) experienced moderate ILI activity.
    • New York City and five states (Arizona, Massachusetts, Nebraska, Nevada, and Wisconsin) experienced low ILI activity.
    • Minimal ILI activity was experienced by the District of Columbia and 16 states (Alaska, Connecticut, Delaware, Iowa, Maine, Michigan, Minnesota, Montana, New Hampshire, North Dakota, Ohio, Oregon, Rhode Island, South Dakota, Vermont, and Washington).
  • The geographic spread of influenza in 37 states was reported as widespread; 10 states reported regional influenza activity; the District of Columbia reported local activity; Puerto Rico, the U.S. Virgin Islands, and three states reported sporadic influenza activity, and Guam reported no influenza activity.  

Global flu activity (see CDC page for current information), was most prominent in the tropical regions of Asia. From February, cases of respiratory disease were high in Singapore and Hong Kong, and 90% of influenza-positive samples were 2009 H1N1. Influenza activity continued to rise in southern China, where 46% of ILI specimens in Week 5 tested positive for influenza, a 3% increase from Week 4. 2009 H1N1 was the predominant subtype.

According to WHO, Madagascar reported an increase in influenza activity, with the co-circulation of influenza B and A (H3N2). There was little influenza activity reported in the tropical regions of the Americas or in sub-Saharan Africa. 


Influenza activity in the majority of North African and Middle Eastern countries appears to have peaked, except for Algeria, where flu activity increased. The percentage of influenza-positive respiratory specimens was also high in Pakistan, Iran and Oman, where 2009 H1N1 and type B viruses co-circulated in relatively equal numbers.
According to the Public Health Agency of Canada, influenza activity increased slightly in Week 5, but remained below the peak reported earlier this season. The percentage of influenza-positive respiratory samples increased from 17% in Week 4 to 19% in Week 5. Since the beginning of the influenza season, 88% of subtyped influenza A specimens have been influenza A (H3N2).
According to the China National Influenza Center, influenza activity rose in recent weeks in northern China. In Week 5, 21% of influenza-like illness (ILI) specimens were influenza-positive, and 2009 H1N1 viruses were predominant. WHO reported that Mongolia saw an increase in 2009 H1N1 virus detections, while Japan saw a sharp increase in ILI activity.
Activity in the Southern Hemisphere remained low.

In Europe, 2 countries (Georgia and Luxembourg) and the Siberian region of the Russian Federation reported very high intensity of influenza activity; 8 countries reported high intensity; 27 reported medium intensity and 4 countries, low intensity. 23 countries reported widespread activity. Of the 25 countries reporting on the impact of influenza on health care systems, 1 (Georgia) reported severe impact; 14 countries reported moderate impact and 10, low impact.

Of the 41 countries reporting on consultation rates for ILI and ARI, 8 (Albania, Belarus, the Czech Republic, Iceland, Kazakhstan, the Republic of Moldova, Serbia and Slovakia) reported increases while 6 (Ireland, Israel, Malta, Norway, Spain and the United Kingdom (England)) reported decreases. Influenza activity has apparently passed its peak in 24 countries in this region. In general, the highest consultation rates were reported for children aged 0–4 and 5–14 years.

WHO/Europe received sentinel surveillance data on hospitalized SARI cases from 9 countries (Armenia, Georgia, Kazakhstan, Kyrgyzstan, Romania, the Republic of Moldova, the Russian Federation, Serbia and Ukraine). Sentinel SARI hospitalizations are at the highest levels observed for the season so far in Georgia and Serbia. In Georgia, however, outpatient clinical consultation rates declined from week 5 to week 6, while the relative percentage of both SARI and ILI specimens testing positive for influenza B increased. Sentinel SARI hospitalizations in Kazakhstan, Kyrgyzstan, Romania and the Russian Federation have declined somewhat from observed peaks in weeks 3–5, but remain notably elevated above pre-season levels, with 30–50% of sentinel SARI specimens testing positive for influenza in each of these countries. Sentinel SARI admissions in the Republic of Moldova and Ukraine are at levels below prior peaks. Nevertheless, a significant percentage of sentinel SARI specimens continue to test positive for influenza, and the proportion of influenza A detections in sentinel SARI specimens in Ukraine increased in week 6. Further information on the sentinel SARI surveillance systems represented in the EuroFlu bulletin can be found in the “Overview of sentinel SARI systems in EuroFlu”.


Table and graphs (Europe)



IntensityGeographic
Spread
ImpactSentinel
swabs
Percentage
positive
Dominant
type
ILI per
100,000
ARI per
100,000
Sentinel
SARI
Virology graph
and pie chart
AlbaniaHighLocalModerate7816.7%Type A, Subtype pH1 and H3503.6(graphs)Click here
ArmeniaMediumLocalModerate333.3%None0.0(graphs)81.4(graphs)

sari
Click here
AustriaMediumNoneLow7068.6%Type A, Subtype pH1N10.0(graphs)33.2(graphs)Click here
AzerbaijanLowSporadicLow170%None292.7(graphs)Click here
BelarusMediumLocalModerate3330.3%Type A, Subtype pH11938.6(graphs)Click here
BelgiumMediumWidespread5362.3%Type B and Type A, Subtype pH1391.1(graphs)1695.1(graphs)Click here
Bosnia and HerzegovinaType A, Subtype pH1(graphs)Click here
BulgariaMediumRegional1428.6%Type A, Subtype pH10.0(graphs)1439.3(graphs)Click here
CroatiaHighWidespreadLowType A, Subtype pH1186.6(graphs)Click here
Czech RepublicMediumWidespread2975.9%Type B and Type A, Subtype pH1N1296.7(graphs)1583.2(graphs)Click here
DenmarkMediumWidespread5125.5%None(graphs)0.0(graphs)Click here
EnglandLowSporadic13711.7%Type A and B18.4(graphs)424.7(graphs)Click here
EstoniaMediumWidespread5534.6%Type A, Subtype pH1N123.1(graphs)502.3(graphs)Click here
FinlandWidespread6271.0%Type B and Type A, Subtype pH10.0(graphs)0.0(graphs)Click here
FranceMediumWidespreadLow23241.4%Type B and Type A, Subtype pH1N10.0(graphs)2824.4(graphs)Click here
GeorgiaVery HighWidespreadSevere5791.2%Type B and Type A, Subtype pH11627.6(graphs)

sari
Click here
GermanyMediumRegional30561.0%Type A, Subtype pH1N10.0(graphs)1342.3(graphs)Click here
GreeceHighWidespread1872.2%Type A, Subtype pH1N1361.0(graphs)0.0(graphs)Click here
HungaryHighWidespreadModerate1629.3%Type A, Subtype pH1587.9(graphs)0.0(graphs)Click here
IcelandMediumRegionalModerate00%57.6(graphs)0.0(graphs)Click here
IrelandMediumWidespreadLow5339.6%Type B50.3(graphs)0.0(graphs)Click here
IsraelMediumWidespreadModerate5853.5%Type A and B52.8(graphs)Click here
ItalyHighWidespreadModerate23036.5%Type A, Subtype pH1N1965.4(graphs)0.0(graphs)Click here
KazakhstanMediumLocalModerate4427.3%None3.1(graphs)422.3(graphs)

sari
Click here
KyrgyzstanLowNoneLow1435.7%Type A and B9.3(graphs)82.4(graphs)

sari
Click here
LatviaMediumWidespread2147.6%Type B and Type A, Subtype pH1(graphs)Click here
Lithuania1457.1%Type B and Type A, Subtype pH1(graphs)Click here
LuxembourgVery HighWidespread10862.0%Type B and Type A, Subtype pH110.2 *(graphs)27.9 *(graphs)Click here
The former Yugoslav Republic of MacedoniaNone(graphs)Click here
MaltaLowLocalLow00%3.6 *(graphs)0 *(graphs)Click here
NetherlandsMediumWidespread3129.0%Type B70.9(graphs)0.0(graphs)Click here
Northern IrelandLowLocalType B35.6(graphs)372.6(graphs)Click here
NorwayMediumWidespread2560.0%Type B145.8(graphs)0.0(graphs)Click here
PolandMediumRegional11429.8%Type A, Subtype pH1180.8(graphs)0.0(graphs)Click here
PortugalMediumWidespread850.0%Type A, Subtype pH150.0(graphs)0.0(graphs)Click here
Republic of MoldovaMediumLocalModerate6966.7%Type B and Type A, Subtype pH1N137.8(graphs)394.3(graphs)

sari
Click here
RomaniaMediumWidespreadModerate5545.5%Type B and Type A, Subtype pH1N193.8(graphs)2855.0(graphs)

sari
Click here
Russian FederationHighWidespreadModerate6645.5%Type A, Subtype pH157.0(graphs)1295.9(graphs)

sari
Click here
ScotlandMediumLocalLow4841.7%Type B8.9(graphs)262.1(graphs)Click here
SerbiaHighRegionalModerate2365.2%Type A, Subtype pH1N1218.2(graphs)

sari
Click here
SlovakiaMediumRegionalModerate572.5(graphs)2820.6(graphs)Click here
SloveniaMediumWidespread3982.1%Type B and Type A, Subtype pH169.6(graphs)1711.9(graphs)Click here
SpainMediumRegional34036.5%Type B152.4(graphs)0.0(graphs)Click here
SwedenHighWidespreadLow5572.7%Type B12.6(graphs)0.0(graphs)Click here
SwitzerlandMediumWidespread312.0(graphs)Click here
TurkeyMediumLocalModerate30450.0%None(graphs)Click here
UkraineMediumLocalLow1428.6%Type B and Type A, Subtype pH14.6 *(graphs)641.4(graphs)

sari
Click here
WalesLowSporadicLow8.3(graphs)0.0(graphs)Click here
Europe310944.2%Click here
Preliminary data

Intensity: Low = no influenza activity or influenza activity at baseline level; Medium= usual levels of influenza activity; High = higher than usual levels of influenza activity; Very high = particularly severe levels of influenza activity.
Percentage positive: percentage of sentinel swabs that tested positive for influenza A or B
Dominant type: this assessment is based on data from sentinel and non-sentinel sources
ARI: acute respiratory infection
ILI: influenza-like illness
Population: per 100,000 population
*: the value in the table for these countries reflects the percent (e.g. from 0.0 to 100.0) of total outpatient encounters that were due to ILI/ARI rather than a consultation rate per 100,000